6 курс / Клинические и лабораторные анализы / Статья_Вельков_В_В_Гликозилированный_гемоглобин_в_диагностике_диабета

63.Radder J.K., van Roosmalen J. HbA1c in healthy, pregnant women//Neth. J. Med. 2005. 63(7): 256–259.

64.Oldfield MD, Donley P, Walwyn L, Scudamore I, Gregory R. Long term prognosis of women with gestational diabetes in a multiethnic population. Postgrad Med J. 2007;83(980):426-

65.Wolf M et al. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care. 2003;26(3):819-824.

66.Qiu C et al. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18(5):3773-84.

67.Di Benedetto A, Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest. 2005;28(1):343-348.

68.Bo S et al Should we consider gestational diabetes a vascular risk factor? Atherosclerosis. 2007;194(2) :e72-79.

69.Tenhola S, Rahiala E, Martikainen A, Halonen P, Voutilainen R Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J Clin Endocrinol Metab 2003 88:1217–1222.

70.Braekke K, Harsem NK, , Staff AC. Oxidative Stress and Antioxidant Status in Fetal Circulation in Preeclampsia Pediatric Res. 2006, 60, 5, 560–564

71. Belo L, et al Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy. 2003; 22(2):129-141

72.Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C- reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003; 59(1):29-37.

73.Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004; 17(2):154-160.

74.Garcia RG et al . Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007; 20(1):98-103

75.Hanson U, Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand. 1998 ;77(6):620-624

76.Hsu CD, Hong SF, Nickless NA, Copel JA. Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia. Am J Perinatol. 1998; 15(3):199-202

77.Temple RC, Aldridge V, Stanley K, Murphy HR. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG. 2006;113(11):1329-1332.

31

78.Ekbom P, Damm P, Nøgaard K, Clausen P, Feldt-Rasmussen U, Feldt-Rasmussen B, Nielsen LH, Mølsted-Pedersen L, Mathiesen ER. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes. Diabetologia. 2000; 43(7):927-931.

79.Nielsen GL, Møller M, Sørensen HT.HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care. 2006; 29(12):2612-2616 .

80.Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003; 20(9):734-738

81.Hu F.B., Manson J.A., Liu S., Hunte D., Coldit G.A., Michel K.B., Speize F.E., Giovannucci E. Prospective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women//J. Natl Cancer. Inst. 1999. 91(6): 542–547.

82. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study//Cancer Epidemiol. Biomarkers Prev. 2004. 13(6): 915–919.

32